✦ LIBER ✦

Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure

✍ Scribed by John R. Teerlink

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

End Point Selection in Acute Decompensat

✍ Reed, Shelby D.; Eapen, Zubin J.; Schulman, Kevin A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 172 KB

End Points for Clinical Trials in Acute

✍ Larry A. Allen; Adrian F. Hernandez; Christopher M. O'Connor; G. Michael Felker 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 473 KB

55: Clinical and Hemodynamic Findings wi

✍ F. Raissi Shabari; R.M. Delgado; B. Kar; A. Civitello; P. Loyalka; B. Czerska; M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Hemodynamic and clinical effects of tezo

✍ G. Torre-Amione; J.B. Young; W.S. Colucci 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Hemodynamic and clinical effects of tezo

✍ Guillermo Torre-Amione; James B Young; Wilson S Colucci; Basil S Lewis; Craig Pr 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Fibrosis as an End Point for Clinical Tr

✍ McHutchison, John; Poynard, Thierry; Afdhal, Nezam 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 561 KB